×

Gitcoin GR12 Is a Win-Win for Aging Research

The Gitcoin platform has funded multiple projects related to aging.

Share







Gitcoin GR12 funding round for longevity.Gitcoin GR12 funding round for longevity.

In recent years, the cryptocurrency community has become increasingly interested in the drive to increase healthy human lifespans.

LLP Vitadao
Visit the VitaDAO website to learn how you can get involved.

Gitcoin introduces longevity research into its funding rounds 

Gitcoin recently held its 12th funding round, and the community has chosen to raise cryptocurrency donations for aging research.

Gitcoin is a platform dedicated to supporting the development of open-source Web3 software, a decentralized architecture based upon blockchain technology. One positive aspect of a decentralized system is that it makes funding of projects for “public goods” possible, which can benefit everyone.

What sets Gitcoin apart is its use of Quadratic Funding. This is an algorithmic crowdfunding approach pioneered by Ethereum co-founder Vitalik Buterin. It is designed to support multiple projects at once and allocate larger matching funds to the most popular projects.

Simply put, the system favors the projects with the largest amount of community support and amplifies the power of smaller donations. Small donations then have a much larger impact, and the matching pool puts that power to work.

VitaDAO stepped up the plate with its selection longevity projects

VitaDAO has curated an excellent selection of longevity related projects during the GR12 funding round. You can see from this chart how much each of the top longevity projects has raised during this funding round.

Longevity Grants

The VitaDAO Longevity Prize raised $175,000 from the donations and matching fund. These funds will split into smaller grants and be awarded to groups achieving specific aging research milestones.

This was inspired by the Methuselah mouse prize, which rewarded breaking the world record for the oldest-ever mouse. Such initiatives are a great way to encourage researchers to push harder and could help the field to progress faster.

The Alliance for Longevity Initiatives raised over $12,000 during the round. This is a new non-profit that provides our movement with the political and lobbying voice it needs in the United states. In order to get therapies approved, we need such an organization to engage with politicians and government agencies.

Lifespan.io also had a number of projects in the GR12 funding round. Perhaps the most important is the Lifespan.io Web3 project, which will bring crowdsourced clinical trials and cryptocurrency together. Almost $65,000 was raised to support this important step towards integrating aging research and cryptocurrency.

The system uses inverse quadratic funding to power decentralized clinical trials that can sidestep the bottlenecks in the traditional centralized system. Essentially it is a variation of quadratic funding designed to drive significant support to a single targeted project, as part of a community-driven platform.

The Lifespan.io Mindset project was also featured and raised over $12,000 for Alzheimer’s disease research. Led by Dr. Oliver Medvedik, the Vice President of Lifespan.io, this represents our first in-house research program.

The project will create a headset that generates light and sound at specific frequencies and may help to combat Alzheimer’s disease.

Medvedik Mother Alzheimer's

Traditional drug approaches to Alzheimer’s disease have yet to succeed, which makes exploring other approaches is very important. Projects like Mindset allow us to explore those other paths and determine if non-drug interventions can impact the disease. If successful, it could be life-changing for people suffering from this awful condition.

Decentralized funding for longevity research

Unfortunately, the traditional scientific grant system is competitive and suffers from a culture of risk aversion. The reticence to fund ambitious projects in favor of more modest ones is an example of this aversion to risk. Grant givers tend to favor projects that are a safer bet and have a higher chance of success.

The journal publication system also suffers from this. Publishers often favor positive results and refuse to publish negative results in the name of good optics over good science.

That said, the traditional grant system is not without some merit and it does indeed fund useful studies and projects. However, having an alternative system like this fills the gap that traditional systems cannot.

The GR12 Finale event

December 17th saw the finale of the funding round, and it was accompanied by a webinar on Youtube. Keith Comito was at the webinar and talked about the role of cryptocurrency transactions as a driving force for aging research.

Conclusion

It’s great to see a rising interest and support for more ambitious research coming from the crypto community. Digital currencies could be the catalyst for funding research differently in the near future.

Decentralized funding could prove to be a decisive factor in the pace of progress in our field in the coming years. We wholeheartedly support initiatives like Gitcoin GR12 and hope to see another funding round with longevity related projects in the future.

We would like to ask you a small favor. We are a non-profit foundation, and unlike some other organizations, we have no shareholders and no products to sell you. We are committed to responsible journalism, free from commercial or political influence, that allows you to make informed decisions about your future health.

All our news and educational content is free for everyone to read, but it does mean that we rely on the help of people like you. Every contribution, no matter if it’s big or small, supports independent journalism and sustains our future. You can support us by making a donation or in other ways at no cost to you.

Longevity and DeSci Recap – July 2023

We’re back with the latest edition of the brand-new Longevity and DeSci Recap. Here, you’ll find the latest interviews, insights,...

Longevity and DeSci Recap – June 2023

Welcome to the premier edition of Lifespan.io's newest release, the Longevity and DeSci Recap. Here, we’ll fill you in on...

Zuzalu: Shining City on the Black Mountain

  Sometime in the early spring of 2023, rumors began to circulate in the longevity community. “Hey, have you heard...

Vitalik Buterin Exclusive Interview: Longevity, AI and More

Vitalik Buterin holding Zuzu, the puppy rescued by people of Zuzalu. Photo: Michelle Lai Don’t try finding Zuzalu on a...

Related Organizations

About the author

Steve Hill

Steve serves on the LEAF Board of Directors and is the Editor in Chief, coordinating the daily news articles and social media content of the organization. He is an active journalist in the aging research and biotechnology field and has to date written over 600 articles on the topic, interviewed over 100 of the leading researchers in the field, hosted livestream events focused on aging, as well as attending various medical industry conferences. His work has been featured in H+ magazine, Psychology Today, Singularity Weblog, Standpoint Magazine, Swiss Monthly, Keep me Prime, and New Economy Magazine. Steve is one of three recipients of the 2020 H+ Innovator Award and shares this honour with Mirko Ranieri – Google AR and Dinorah Delfin – Immortalists Magazine. The H+ Innovator Award looks into our community and acknowledges ideas and projects that encourage social change, achieve scientific accomplishments, technological advances, philosophical and intellectual visions, author unique narratives, build fascinating artistic ventures, and develop products that bridge gaps and help us to achieve transhumanist goals. Steve has a background in project management and administration which has helped him to build a united team for effective fundraising and content creation, while his additional knowledge of biology and statistical data analysis allows him to carefully assess and coordinate the scientific groups involved in the project.
No Comments
Write a comment:

*

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.